Helixmith ranked among the top searched stocks on 4 days within the past month.
As of 12:30 PM on the 23rd, Helixmith is trading at 32,700 KRW, the same price as the previous day. This represents a 76.76% increase compared to October 30. Helixmith is known as a specialized company developing new drugs focused on gene therapy.
Today, foreigners have tentatively net purchased 59,104 shares. Over the past 5 days, individual investors have net purchased 25,521 shares, while foreigners and institutions have net sold 132,335 shares and net purchased 105,295 shares, respectively.
On November 20, Helixmith was a market topic with the headline "'Engensis' US Phase 3-2 Clinical Trial First Dosing Sparks Second Day of Sharp Rise."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

